| |
A polyherbal
formulation New Diarex was tested in 50 patients with acute and chronic
diarrhoea. A dose of 2 tablets three times daily for 3 days followed
by 1 tablet thrice daily for 2 days was administered in acute diarrhoea.
Chronic diarrhoea patients were given 2 tablets thrice daily for 10
days. There was a significant reduction in frequency of stools in
acute as well as chronic diarrhoea. The associated symptoms were also
controlled.
Diarrhoeal
diseases are notorious for the huge morbidity and mortality they
inflict on human population1-3. Diarrhoea is formally
defined as an increase in the frequency, fluidity or volume (weight)
of bowel movements relative to the usual habits of the individual.
Changes in the characteristics of the stools may also be associated
with abdominal pain, rectal discomfort or tenesmus or passage of
blood, mucous or pus4. It is considered acute when it
lasts less than 7 - 14 days and chronic when it lasts more than
2-3 weeks. Diarrhoeal diseases due to their high mortality rates
have always drawn the attention to adopt more measures for their
control. In Ayurveda herbal drugs are used to treat diarrhoeal diseases5-6.
New Diarex, an herbal formulation has been found to have antidiarrhoeal
properties in experimental and pilot clinical studies7-9.
The herbal formulation consists of Musta, Bilwa, Dadima and Kutaja.
In
the present study 50 indoor and outdoor patients of uncomplicated
acute and chronic diarrhoea were selected randomly from the Department
of Kayachikitsa, S.S. Hospital, B.H.U., Varanasi. The necessary
investigations and relevant clinical symptomatology were evaluated
before and after treatment to draw conclusions regarding the effect
of New Diarex. Besides routine clinical examination of general symptomatology,
certain laboratory investigations like stool, urine and blood were
also done to confirm the diagnosis and to evaluate the response.
Treatment
schedule
Dose:
New Diarex was given at a dose of two tablets thrice daily.
Duration:
In acute diarrhoea the drug was given at a dose of two tablets thrice
daily for 3 days followed by one tablet thrice daily for 2 days.
Criteria
of Assessment: The final assessment of response was done on
the basis of its effectiveness in relieving clinical symptoms and
eradication of pathogens in stool culture.
| Table
1: Age incidence in 50 cases of diarrhoea |
|
Age
groups (years)
|
No.
of patients
|
Percentage
|
|
10-20
|
6
|
12
|
|
21-30
|
28
|
46
|
|
31-40
|
12
|
24
|
|
>40
|
4
|
8
|
|
Total
|
50
|
100
|
| Table
2: Sex incidence in 50 cases of diarrhoea |
|
Sex
|
No.
of patients
|
Percentage
|
|
Female
|
20
|
40
|
|
Male
|
30
|
60
|
|
Total
|
50
|
100
|
|
Table
3: Showing incidence of duration of illness in 50 cases of
diarrhoeal diseases
|
|
Grade
|
No.
of patients
|
Percentage
|
|
I
(0-10/d)
|
29
|
58
|
|
II
(11-30/d)
|
9
|
18
|
|
III
(1-6/m)
|
4
|
8
|
|
IV
(>6/m)
|
8
|
16
|
|
Total
|
50
|
100
|
The
present clinical trial was conducted to study the antidiarrhoeal
activity of New Diarex which contain four common herbs, Musta, Bilwa,
Dadima and Kutaja, used commonly in Ayurveda. Ayurvedic drugs not
only act as antidiarrhoeal agents in acute diarrhoea but also correct
the entire system to bring about symptomatic relief in associated
symptoms, therefore the above combination was also tried in patients
of chronic diarrhoea. A total of 50 patients registered for the
trial, out of which 12 patients (24%) presented with diarrhoeal
symptoms for more than a month. These patients were diagnosed with
chronic diarrhoea and were given the trial drug at a dose of 2 tablets
thrice a day for 10 days. The rest of the patients (76%) were suffering
from acute diarrhoea, who received the trial drug, 2 tablets thrice
a day, for 3 days, followed by one tablet thrice a day for 2 days.
Seventy percent of the patients were between 21-40 years (Table
1). There was a 60:40 ratio of male to female patients (Table 2).
|
Table
4: Showing response of the treatment on frequency of loose
motions
|
|
Before
treatment
|
After
treatment
|
|
No.
of patients
|
%
|
No.
of patients
|
%
|
|
0
(2-3/d)
|
0
|
0
|
35
|
70
|
|
I
(3-6/d)
|
21
|
42
|
14
|
28
|
|
II
(7-10/d)
|
17
|
34
|
1
|
2
|
|
III
(>10/d)
|
12
|
24
|
0
|
0
|
|
Total
|
50
|
100
|
50
|
100
|
A
definite decrease in the frequency of motions was recorded in almost
all the patients. Improvement was also recorded in consistency of
stools which was initially watery/loose in most of the patients
and became semisolid to normal in all the patients. The other associated
features like pain during defecation, gas formation, mucous in the
stools, postprandial abdominal discomfort also significantly reduced.
Frequency of 3-6 motions/day decreased in 14 patients
after treatment compared to 21 patients before treatment. Out of
17 patients who showed frequency of 7-10/day before treatment, 16
showed improvement. All the 12 patients with frequency of more than
10/day improved completely (Table 4).
Thus,
the preliminary study conducted in 50 patients of diarrhoeal diseases,
irrespective of their aetiology, using the four commonly used Ayurvedic
antidiarrhoeal agents, showed a marked reduction in the frequency
and consistency of the stools in the short trial period. It is important
to note that patients suffering from several months with chronic
diarrhoea also responded positively to the trial treatment. Decrease
in the suffering of patients was noted as evidenced from symptomatic
improvement, shown in the tables. The trial drug has been found
to be useful in bringing about a relief of moderate to significant
degree of symptomatic relief. More intensive investigations and
a larger number of patients are needed to make positive claims,
but based on the results of the present preliminary study, it can
be definitely concluded that New Diarex is a moderate to
highly effective remedy in the management of non specific diarrhoea
and it is recommended to be used in all patients with the ailment
with definite results.
|
Table
5: Showing the response of treatment based on the symptomatological
changes
|
|
Before
treatment
|
After
treatment
|
|
No.
of patients
|
%
|
No.
of patients
|
%
|
| Painful
defecation |
42
|
84
|
9
|
18
|
| Watery/loose |
47
|
94
|
0
|
0
|
| Semi-solid |
3
|
6
|
12
|
24
|
| Normal |
0
|
0
|
38
|
76
|
| Change
in bowel habit |
35
|
70
|
13
|
26
|
| Postprandial
call |
29
|
58
|
16
|
32
|
| Gas
formation |
32
|
64
|
20
|
40
|
| Stool
with mucous/blood |
15
|
30
|
7
|
14
|
| Abdominal
discomfort |
12
|
24
|
6
|
12
|
| Anorexia |
4
|
8
|
2
|
4
|
| Nausea |
37
|
54
|
8
|
16
|
| Vomiting |
40
|
80
|
38
|
76
|
| Weight
loss |
2
|
4
|
2
|
4
|
We
are highly thankful to Dr. S.K. Mitra, M.D., Executive Director,
Research and Technical Services, The Himalaya Drug Company, Bangalore,
for financial and technical support to the present project.
- Harrisons
Principles of Internal Medicine, 15th Edition, Braunwald,
Fauci, Kasper, Hauser, Longo and Jameson, The McGraw-Hill Companies,
Inc., New York. Vol. 1, 2001.
- Nadkarni,
A.K. Indian Materia Medica. Revised edition, Popular Prakashan
Pvt. Ltd., Bombay, 1982.
- Kirtikar,
K.R. and Basu, B.D. Indian Medicinal Plants. International
Book Distributors, Dehradun, 2nd Edition, 1984.
- Puratchikody,
A., Jaswanth, A., Nagalakshmi, A., Anagumeenal, P.K. and Ruckmani,
K. Antibacterial activity of Cyperus rotundus Linn. Indian
Journal of Pharmaceutical Sciences (2001): (July-August),
326-327.
- Singh, K.P.
Clinical studies on amebiasis and giardiasis evaluating the efficacy
of Kutaja (Holorrhena antidysenterica) in Entamoeba
histolytica cyst passers. Ancient Science of Life 1986;
5(4): 228-231.
- Dineshchandra,
S.K., Dixit, S.K., Sen, P.C. and Joshi, D. An experimental study
of Kutajarishta with special reference to amebiasis. Ancient
Science of Life 1988; 8(2):100-102.
- Yadav, S.K.,
Jain, A.K., Triphathi, S.N. and Gupta, J.P. Irritable bowel syndrome:
Therapeutic evaluation of indigenous drugs. Indian Journal
of Medical Research 1989; 90:496-503.
- Trivedi,
V.P., Nesamay, S and Sharma, V.K. A clinical study of effects
of Bilwa-Majja churna on intestinal parasites (Udar krimi). Journal
of Research Indian Medicine & Yoga 1978; 13(2): 28-35.
- Haider, R.,
Abdul Kalam, A.K., Sultanlal Aziz, K.M., Chowdhury, A and Kabir,
I. Evaluation of indigenous plants in the treatment of acute Shigeollosis.
Tropical and Geographical Medicine 1991; 43: 266-270.
|
 |